[Event Report] Expert Meeting “The Future of Healthcare in Japan and Cost-Effectiveness Assessment” (December 14, 2018)
date : 12/17/2018
Tags: Future of the Health Care System, Innovation and Sustainability
HGPI and National Graduate Institute for Policy Studies (GRIPS) jointly convened the Expert Meeting “The Future of Healthcare in Japan and Cost-Effectiveness Assessment”.
Health Technology Assessment (HTA) is gaining prominence around the world as a means of appropriately assessing medical treatments. In Japan, since 2012 there have been many discussions held on the introduction of HTA, particularly at the Committee for Cost-Effectiveness Assessment within the Central Social Insurance Medical Council (Chuikyo). A trial introduction of Cost-Effectiveness Assessment was started in FY2016, and the issues and lessons that emerged through this trial introduction were reviewed in FY2017. In FY2018, the issues and lessons that emerged through the trial introduction have been discussed, while many other reviews have also been conducted with the aim of realizing the full-scale introduction of this unique endeavor by Japan to adjust the prices of pharmaceuticals and medical devices based on the results of Cost-Effectiveness Assessment.
Since 2016, the Health and Global Policy Institute (HGPI) has organized expert meetings and exchanges of opinions based on the theme “Rebalancing Healthcare Systems: Innovation and Sustainability.” In 2018, HGPI helped to deepen discussions by organizing five consecutive meetings.
At this meeting, leading experts from Japan and abroad discussed the issues identified so far and various stakeholders considered the respective roles that they should play, as well as the possible pathways toward resolving the issues.
*For past activities, please refer to the “Summary of Discussions in Past HGPI Meetings for the “Rebalancing Healthcare Systems: Innovation and Sustainability” Series (attached below).
■Overview
Opening (Explanation of the objectives of the meeting)
- Matt McEnany (Manager, Health and Global Policy Institute)
Opening Remarks
- Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
Keynote Address 1 “Current Issues and the Future Outlook for the Sustainability of the Japanese Healthcare System”
- Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University/ Public Member, Central Social Insurance Medical Council (Chuikyo)/ Chairperson, Chuikyo Special Committee on Drug Prices/ Acting Chairperson, Chuikyo Committee for Cost-Effectiveness Assessment)
Keynote Address 2 “Shifts to this Point and the Future Direction for Discussion Around Cost Effectiveness Assessments in Japan”
- Shigekazu Komoto (Counselor for Policy Planning, Coordination, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
Panel Discussion: “Issues and Future of Cost-Effectiveness Assessment – Toward a Unique Endeavor by Japan”
Panelists:
- Isao Kamae (Project Professor, Graduate School of Public Policy, The University of Tokyo)
- Hideo Kunitoh (Division of Chemotherapy, Department of Internal Medicine, Japanese Red Cross Medical Center)
- Shigekazu Komoto (Counselor for Policy Planning, Coordination, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
- Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
- Chris Hourigan (Vice Chair, Pharmaceutical Research and Manufacturers of America (PhRMA))
Moderator:
- Joji Sugawara (Associate, Health and Global Policy Institute)
Closing Remarks
- Keizo Takemi (Member of the House of Councillors)
(No particular order, titles omitted)
(Photographed by: Kazunori Izawa)
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)